Loading...
Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab
PURPOSE: We intended to determine whether dexrazoxane (DZR) is cardioprotective during administration of adjuvant anthracycline-based chemotherapy followed by a 1-year trastuzumab treatment. METHODS: The medical records of 228 patients who underwent surgical resection and received adjuvant chemother...
Na minha lista:
| Udgivet i: | J Breast Cancer |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Breast Cancer Society
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378583/ https://ncbi.nlm.nih.gov/pubmed/28382098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2017.20.1.82 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|